ArticleFrontiers in pharmacology2025

Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases.

Chengzhu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.